Dr. sc. hum. Henrik Jungaberle
Henrik Jungaberle is a public health, drug and prevention researcher. His focus is on human development, integration and integrity in the use of psychoactive substances – and shaping this on the individual, social and political level. He develops and implements strategies to avoid or minimize the negative consequences of alcohol and other drug use. On the other hand he works on strategies to sustain and improve health through the professional application of psychedelic substances. Currently he is part of the research team in the EPIsoDE study – a psilocybin-assisted depression treatment trial.
Henrik Jungaberle is the director and co-founder of MIND European Foundation for Psychedelic Science and one of the CEO’s of OVID Health Systems. Henrik is one of the Scientific Directors of the INSIGHT Conference(s).
He has worked at the Institute of Medical Psychology, University Hospital Heidelberg, for 18 years (1996-2014) where he conducted and lead EU- and DFG-financed research on salutogenesis and psychoactive substances. With his teams he built programs like REBOUND (drug education) and BEYOND EXPERIENCE (psychedelic integration and harm reduction).